Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionDual inhibitor of the bacterial enzymes DNA gyrase subunit B (GyrB) and topoisomerase IV Par E subunit (ParE)
Molecular Target DNA gyrase subunit B (GyrB) ; Topoisomerase IV Par E subunit (ParE)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentPreclinical
Standard IndicationGram-negative bacterial infection
Indication DetailsTreat Gram-negative bacterial infections
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today